Gastroenterology & GI Surgery

Welcome to the Mayo Clinic Gastroenterology & GI Surgery Page! With one of the largest group of digestive disease specialists in the world, Mayo Clinic has been recognized as the nation's best Gastroenterology & GI Surgery hospital by U.S. News & World Report. Follow the page to learn about clinical trials and up-to-date research, and find resources for all your gastroenterology needs. Our goal is to connect you to others, and become informed decision makers; so post a comment, share your story, own your health.

PUBLIC PAGE
Wed, Apr 17 9:49am

Rituximab Maintenance Therapy for Autoimmune Pancreatitis

By Kanaaz Pereira, Connect Moderator, @kanaazpereira

IgG4-RD or immunoglobulin G4-related disease can affect almost any organ in the body. It’s manifestation is most often seen in the pancreas – autoimmune pancreatitis – or in the bile ducts and liver, where it is known as IgG4-related sclerosing cholangitis or IgG4-associated cholangitis.

The dramatic response to steroids makes autoimmune pancreatitis (AIP) unique among pancreatic disorders, but many cases are steroid-resistant, and relapse is common after steroid withdrawal. Mayo Clinic gastroenterologist, Dr. Mark Topazian discusses a recent study which shows that rituximab maintenance therapy can prolong remission.

So what are some "take home” messages from this study?

  • Although patients with type 1 AIP have a dramatic response to steroid treatment, disease relapses are common.
  • About 30 to 50 percent of the time, AIP returns, requiring additional treatment, sometimes long term.If relapse occurs after corticosteroid treatment or corticosteroid treatment is not tolerated, immunomodulators (IM) may be used. Immunosuppressants and immunomodulators include mercaptopurine (Purinethol, Purixan), azathioprine (Imuran, Azasan) and rituximab (Rituxan).
  • Nearly half of patients treated with IMs relapse during treatment.
  • However, rituximab treatment is highly effective for induction and maintenance of remission in patients with autoimmune pancreatitis with or without IgG4-related sclerosing cholangitis, including those who are resistant to IM treatment.

Meet other people talking about autoimmune pancreatitis, including other IgG4-related diseases on Mayo Clinic Connect. Join the conversation, share experiences, ask questions, and discover your support network...

Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Gastroenterology & GI Surgery page.

We'll include this text in the user's invitation.